Durvalumab Success Signifies New Era in Stage III NSCLC

2018-03-29 02:00:00

Edward S. Kim, MD, recaps the findings from the PACIFIC trial of durvalumab and discussed the treatment of patients with stage III NSCLC.


  • Save
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply